Bioceres Crop Solutions (BIOX) Stock
Latin American agricultural biotech firm developing crop traits. Here's the price, business snapshot, and what's worth knowing about Bioceres Crop Solutions in October 2026.
Bioceres Crop Solutions Corp (BIOX) is an agricultural biotechnology and seed company focused on developing and commercialiseable crop traits, seed treatments and biological products for farmers. The firm works on technologies intended to improve crop resilience and input efficiency, and it has commercial activities and partnerships primarily in Latin America with ambitions to expand. As a small‑cap company (market capitalisation approximately $110.37M), its shares can be more volatile than larger peers and sensitive to regulatory approvals, commodity prices, adoption rates and country‑specific risks such as currency and policy in its key markets. Investors should consider the long‑term nature of agricultural R&D and the uncertainty of regulatory and market adoption outcomes. This is general educational information and not personalised investment advice; suitability depends on your circumstances and investing in equities can lead to losses.
Bioceres Crop Solutions (BIOX) Stock Forecast
Analyst price target, next 12 months
$21.00
+6043.9% vs today's $0.34
Price range over the last 12 months
Close to its 12-month low
Analysts covering Bioceres Crop Solutions have a consensus 12-month target of $21.00, above the current price of $0.34.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 30 Sep 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying Bioceres stock with a target price of $21, indicating significant growth potential.
Financial Health
Bioceres Crop Solutions Corp shows moderate revenue and profit levels, with room for improvement.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Growth through traits
Development and commercialisation of seed traits and biologicals could expand revenue if farmers adopt new technologies, though adoption and regulation are uncertain.
Latin America exposure
A strong presence in Latin America offers market familiarity and growth opportunities, but brings currency and country‑specific regulatory and policy risks.
R&D and partnerships
Progress depends on R&D outcomes and strategic partnerships which can accelerate commercialisation, yet research timelines and results are inherently uncertain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
